Management of Neuropathic Pain in MS Patients

Pharmacological Interventions

• The American Society of Clinical Oncology recommends duloxetine as a first-line pharmacological option for neuropathic pain with numbness and tingling, with moderate-strength evidence supporting its use 1, 2, 3
• Duloxetine has intermediate-quality evidence for painful neuropathy, and requires 3-4 months at therapeutic dose to see pain reduction 1, 4
• The American Society of Clinical Oncology states that no recommendation can be made for gabapentin/pregabalin in treating established neuropathy due to low evidence quality 1, 5
• Tricyclic antidepressants (nortriptyline or desipramine) are first-line options for neuropathic pain, though they require careful titration and have anticholinergic side effects 2

Non-Pharmacological Interventions

• Physical activity has moderate evidence (Level IA) for neuropathy management and should be offered alongside pharmacological treatment 3
• Acupuncture may provide benefit for neuropathic pain, though larger studies are needed to confirm efficacy 1, 5

Red Flags Requiring Urgent Intervention

• Bilateral symptoms or ascending pattern could suggest more extensive CNS involvement, and requires urgent neurological evaluation 1, 6